Page last updated: 2024-12-07

arginylphenylalaninamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Arginylphenylalaninamide (Arg-Phe-NH2) is a dipeptide that has been studied for its potential therapeutic effects. It is a derivative of the naturally occurring dipeptide arginine-phenylalanine (Arg-Phe). Arg-Phe-NH2 has been shown to have various biological activities, including:

* **Antioxidant properties:** Arg-Phe-NH2 has been reported to scavenge free radicals and protect cells from oxidative damage.
* **Neuroprotective effects:** Studies have suggested that Arg-Phe-NH2 may protect neurons from damage caused by neurotoxins and other insults.
* **Anti-inflammatory activity:** Arg-Phe-NH2 has been shown to reduce inflammation in animal models.
* **Wound healing properties:** Arg-Phe-NH2 has been investigated for its potential to promote wound healing.

The synthesis of Arg-Phe-NH2 typically involves coupling the amino acids arginine and phenylalanine using standard peptide synthesis techniques.

The study of Arg-Phe-NH2 is driven by its potential therapeutic applications in various diseases and conditions, including neurodegenerative disorders, inflammatory diseases, and wound healing. Further research is ongoing to explore its mechanisms of action and to develop its therapeutic potential.
'

arginylphenylalaninamide: RN given refers to (L,L)-isomer; fragment of FMRamide; may be used as a neurotransmitter or neuromodulator by optic lobe neurons of different types [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID122185
CHEMBL ID3343990
SCHEMBL ID1373212
MeSH IDM0162086

Synonyms (17)

Synonym
rfamide
34388-59-5
(2s)-2-amino-n-[(2s)-1-amino-1-oxo-3-phenylpropan-2-yl]-5-(diaminomethylideneamino)pentanamide
arg-phe-nh2
arginylphenylalaninamide
l-phenylalaninamide, l-arginyl-
h-arg-phe-nh2
119051-99-9
SCHEMBL1373212
CHEMBL3343990 ,
r-f-nh2
(s)-2-amino-n-((s)-1-amino-1-oxo-3-phenylpropan-2-yl)-5-guanidinopentanamide
bdbm50497461
arginyl-phenylalanine amide
DTXSID20955942
2-amino-5-carbamimidamido-n-(1-hydroxy-1-imino-3-phenylpropan-2-yl)pentanimidic acid
AKOS040746587
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (3)

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Mas-related G-protein coupled receptor member X1Mus musculus (house mouse)EC50 (µMol)0.50120.25120.34220.5012AID1167972
Mas-related G-protein coupled receptor member X1Rattus norvegicus (Norway rat)EC50 (µMol)6.30960.30003.30886.3096AID1167971
Mas-related G-protein coupled receptor member X1Homo sapiens (human)EC50 (µMol)100.00000.05000.42220.7943AID1167970
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (5)

Processvia Protein(s)Taxonomy
acute-phase responseMas-related G-protein coupled receptor member X1Homo sapiens (human)
signal transductionMas-related G-protein coupled receptor member X1Homo sapiens (human)
cell surface receptor signaling pathwayMas-related G-protein coupled receptor member X1Homo sapiens (human)
response to chloroquineMas-related G-protein coupled receptor member X1Homo sapiens (human)
G protein-coupled receptor signaling pathwayMas-related G-protein coupled receptor member X1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (2)

Processvia Protein(s)Taxonomy
transmembrane signaling receptor activityMas-related G-protein coupled receptor member X1Homo sapiens (human)
G protein-coupled receptor activityMas-related G-protein coupled receptor member X1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (2)

Processvia Protein(s)Taxonomy
cell surfaceMas-related G-protein coupled receptor member X1Homo sapiens (human)
plasma membraneMas-related G-protein coupled receptor member X1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID1167975Antagonist activity at human MrgX1 transfected in HEK293 cells at 200 uM by FLIPR assay2014Bioorganic & medicinal chemistry, Nov-01, Volume: 22, Issue:21
Peptidomimetics of Arg-Phe-NH2 as small molecule agonists of Mas-related gene C (MrgC) receptors.
AID1167972Agonist activity at mouse MrgC11 transfected in HEK293 cells by FLIPR assay2014Bioorganic & medicinal chemistry, Nov-01, Volume: 22, Issue:21
Peptidomimetics of Arg-Phe-NH2 as small molecule agonists of Mas-related gene C (MrgC) receptors.
AID1167971Agonist activity at rat MrgX1 transfected in HEK293 cells by FLIPR assay2014Bioorganic & medicinal chemistry, Nov-01, Volume: 22, Issue:21
Peptidomimetics of Arg-Phe-NH2 as small molecule agonists of Mas-related gene C (MrgC) receptors.
AID1167970Agonist activity at human MrgX1 transfected in HEK293 cells by FLIPR assay2014Bioorganic & medicinal chemistry, Nov-01, Volume: 22, Issue:21
Peptidomimetics of Arg-Phe-NH2 as small molecule agonists of Mas-related gene C (MrgC) receptors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (81)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (3.70)18.7374
1990's25 (30.86)18.2507
2000's24 (29.63)29.6817
2010's21 (25.93)24.3611
2020's8 (9.88)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.00

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.00 (24.57)
Research Supply Index4.42 (2.92)
Research Growth Index5.42 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.00)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews6 (7.32%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other76 (92.68%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]